Lung Neoplasms: all 7,333 studies
Page 71 of 74. Open to participants first (1,554), then studies with results posted, then the rest; newest registration first within each.
- Combination Chemotherapy and Imatinib Mesylate in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00052494Phase 1
- Bortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung CancerCompletedNCT00052338Phase 1
- Mistletoe in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Are Receiving Palliative ChemotherapyStatus unknownNCT00052325Phase 2
- Phase 2 Study of VELCADE Alone or VELCADE® Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00051974Phase 2
- Safety/Efficacy Study of Immunoconjugate With Docetaxel in Non-small Cell Lung CarcinomaCompletedNCT00051571Phase 2
- ALIMTA(Pemetrexed)/Cisplatin and ALIMTA(Pemetrexed)/Carboplatin in Extensive Stage Small Cell Lung Cancer.CompletedNCT00051506Phase 2
- ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.CompletedNCT00051493Phase 2
- Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung CancerCompletedNCT00050973Phase 3
- A Phase 2, Randomized, Open-Label Study Of Single Agent CI-1033 In Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00050830Phase 2
- Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung CarcinomaCompletedNCT00050674Phase 2
- Study of Lonafarnib in Combination With Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer (Study P01901)(TERMINATED)TerminatedNCT00050336Phase 3
- Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid TumorsTerminatedNCT00049608Phase 1
- Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00049218Phase 1/2
- Iressa/Docetaxel in Non-Small-Cell Lung CancerWithdrawnNCT00048087Phase 2
- This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer.CompletedNCT00047840Phase 2
- A Study With Tarceva and Chemotherapy vs. Chemotherapy Alone in Patients With Advanced Lung CancerCompletedNCT00047736Phase 3
- Efficacy and Safety Study of OSI-211 (Liposomal Lurtotecan) to Treat Recurrent Small Cell Lung CancerCompletedNCT00046787Phase 2
- S0122: Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Limited-Stage Small Cell Lung CancerTerminatedNCT00045617Phase 2
- Imatinib Mesylate and Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00045604Phase 1
- Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive AdultsCompletedNCT00043927Phase 3
- The Study Of An Oral Drug Called A Radiation Sensitizer In Patients With Newly Diagnosed Small Cell Lung Cancer (SCLC)CompletedNCT00043862Phase 2
- Avastin and Tarceva for Locally Advanced or Metastatic Non-Squamous Non-Small-Cell Lung CancerCompletedNCT00043823Phase 1/2
- Carboplatin and Etoposide With or Without Oblimersen Sodium in Treating Patients With Extensive Stage Small Cell Lung CancerCompletedNCT00042978Phase 2
- Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung CancerTerminatedNCT00042835Phase 1
- A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.CompletedNCT00042679Phase 2
- A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Vinorelbine as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT00042315Phase 3
- A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Paclitaxel/Carboplatin as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT00042302Phase 3
- Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the LiverCompletedNCT00041808Phase 1/2
- Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00041314Phase 2
- Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00041054Phase 2
- EF5 in Assessing Tumor Response to Anticancer Therapy in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung CancerCompletedNCT00041028Phase 2
- Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00041015Phase 3
- Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05)CompletedNCT00040885Phase 3
- Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung CancerCompletedNCT00040794Phase 2
- Bortezomib in Treating Patients With Advanced Non-small Cell Lung CancerTerminatedNCT00040768Phase 2
- Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung CancerStatus unknownNCT00040560Phase 1
- Radiofrequency Ablation During Surgery in Treating Patients With Non-Small Cell Lung CancerCompletedNCT00039507Phase 2
- Erlotinib in Treating Patients With Malignant Mesothelioma of the LungCompletedNCT00039182Phase 2
- Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung CancerTerminatedNCT00039091Phase 1
- Intravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast CancerCompletedNCT00039052Phase 1
- Combination Chemotherapy Followed by Radiation Therapy With or Without Paclitaxel in Treating Patients With Unresectable Stage III Non-Small Cell Lung CancerStatus unknownNCT00039039Phase 3
- Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural MalignanciesCompletedNCT00037817Phase 1
- Survival in a Randomized Phase III Trial in Patients With Limited Disease (LD) Small Cell Lung Cancer Vaccinated With Adjuvant BEC2 and BCGCompletedNCT00037713Phase 3
- TLK286 in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00036920Phase 2
- Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerCompletedNCT00036790Phase 1
- OSI-774 (Tarceva) in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00036647Phase 3
- Chemotherapy Related Anemia in Patients With Non-Myeloid MalignanciesCompletedNCT00036023Phase 2
- Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)CompletedNCT00034957Phase 2
- Study of Temozolomide in the Treatment of Brain Metastasis From Non-small-cell Lung Cancer (Study P02143)TerminatedNCT00034697Phase 2
- Comparing 3 Schedules of Alimta Plus GemzarCompletedNCT00034606Phase 2
- Study of Cetuximab in Combination With Carboplatin-Paclitaxel in Non-Small Cell Lung CancerCompletedNCT00034541Phase 1/2
- ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)CompletedNCT00034346Phase 2
- Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2CompletedNCT00034281Phase 1
- A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung CancerCompletedNCT00034268Phase 3
- Lometrexol Plus Folic Acid in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerStatus unknownNCT00033722Phase 2
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNCT00033696Phase 2
- Comparison of Nicotine Inhaler and/or Bupropion in Helping People to Stop Smoking and Prevent the Recurrence of SmokingCompletedNCT00033592Phase 3
- Combination Chemotherapy and Computer-Planned Radiation Therapy in Treating Patients With Unresectable Stage III Non-Small Cell Lung CancerCompletedNCT00033553Phase 2
- INS316 Compared With Saline for Sputum Collection in Diagnosing Lung CancerStatus unknownNCT00033527Not applicable
- Chemotherapy, Tirapazamine, and Radiation Therapy in Treating Patients With Non-Small Cell Lung CancerCompletedNCT00033410Phase 1
- CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung CancerCompletedNCT00033384Phase 2
- S0002 - A Program to Quit Smoking With or Without Bupropion in Treating Patients With Stage I or II Non-Small Cell Lung Cancer Who Have Undergone SurgeryTerminatedNCT00032084Phase 3
- Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung CancerCompletedNCT00032032Phase 1
- Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung CancerCompletedNCT00031785Phase 3
- 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)CompletedNCT00031681Phase 1
- Combination Chemotherapy Followed by Radiation Therapy Before Surgery in Treating Patients With Stage IIIB NSCLCCompletedNCT00030810Phase 2
- Preoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC PatientsCompletedNCT00030771Phase 3
- Docetaxel With or Without Oblimersen in Treating Patients With Non-Small Cell Lung CancerStatus unknownNCT00030641Phase 2/3
- Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionCompletedNCT00030498Phase 1
- Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant MesotheliomaStatus unknownNCT00030459Phase 2
- S0119: Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00030433Phase 2
- Celecoxib and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00030420Phase 2
- Celecoxib and Docetaxel in Treating Patients With Non-Small Cell Lung CancerCompletedNCT00030407Phase 2
- Gefitinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00029003Phase 2
- Chemotherapy and Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung CancerCompletedNCT00028938Phase 3
- Combination Chemotherapy With or Without Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung CancerCompletedNCT00028925Phase 2
- EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural CancerTerminatedNCT00028782Not applicable
- Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid TumorsCompletedNCT00028535Phase 1
- CCI-779 in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00028028Phase 2
- Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant MesotheliomaCompletedNCT00027703Phase 2
- Ecteinascidin 743 in Treating Patients With Malignant MesotheliomaTerminatedNCT00027508Phase 2
- S0027: Vinorelbine Followed by Docetaxel in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00026156Phase 2
- Photodynamic Therapy With HPPH in Treating Patients With Non-Small Cell Lung CancerCompletedNCT00025571Phase 1
- Tipifarnib Plus Radiation Therapy After Combination Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung CancerCompletedNCT00025480Phase 1
- Bevacizumab, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung CancerCompletedNCT00025389Phase 2
- Combination Chemotherapy Plus Thalidomide in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00025285Phase 2
- Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00025272Phase 2
- Gefitinib in Treating Patients With Malignant MesotheliomaCompletedNCT00025207Phase 2
- Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung CancerCompletedNCT00024076Phase 2
- SU006668 in Treating Patients With Advanced Solid TumorsStatus unknownNCT00024063Phase 1
- Vaccine Therapy in Treating Patients With Non-Small Cell Lung CancerCompletedNCT00023985Phase 1
- Temozolomide in Treating Patients With Relapsed or Progressive Small Cell Lung CancerCompletedNCT00022711Phase 2
- Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerCompletedNCT00022646Phase 2
- Chemotherapy and Radiation Therapy in Treating Patients With Non-Small Cell Lung CancerCompletedNCT00022308Phase 1
- T138067 in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer That Has Not Responded to Previous ChemotherapyStatus unknownNCT00022243Phase 2
- Docetaxel in Treating Patients With Non-Small Cell Lung CancerStatus unknownNCT00022022Phase 3
- Gemcitabine Plus Supportive Care in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerStatus unknownNCT00022009Phase 2/3
- Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung CancerCompletedNCT00021333Phase 2
- Computer-Assisted Scheduling of Nicotine Inhaler Use in Participants Who Plan to Stop SmokingCompletedNCT00021138Not applicable
- Combination Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Stage IIIB Non-Small Cell Lung CancerTerminatedNCT00021112Phase 2